Human SNP ID | rs286913 |
---|---|
Human chromosome | chr11 |
Human SNP position | 34633816 |
Pig chromosome | chr2 |
Pig SNP position | 28687082 |
PubMed ID | 21107309 |
---|---|
Journal | Neuropsychopharmacology |
Link | www.ncbi.nlm.nih.gov/pubmed/21107309 |
Study | Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 738 European ancestry, African American, and other ancestry cases |
Replication sample | NA |
Region | 11p13 |
Chromosome id | chr11 |
Chromosome position | 34633816 |
Reported gene | EHF |
Mapped gene | EHF |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 26298 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs286913-? |
SNPs | rs286913 |
Merged | 0 |
SNP id current | 286913 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | 0.05 |
P value | 0.00000007 |
Pvalue mlog | 7.15490195998574 |
P value text | (Ziprasidone, vigilance) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to antipsychotic drug |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097332 |
Study accession | GCST000884 |